Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSC Coated Fistula Plug for Cryptoglandular Perianal Fistulas
NCT02589119Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2016
- Primary completion
- Sep 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous mesenchymal stromal cells in cryptoglandular perianal fistula, sponsored by Mayo Clinic. Primary endpoint: Number of participants with treatment-related adverse events. Started Jan 2016; status: completed.
02
Drugs
autologous mesenchymal stromal cells
03
Conditions
cryptoglandular perianal fistula
Beyond the preview
Go deeper on NCT02589119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02589119.